Prospective, Longitudinal, Non-Interventional study of Disease Burden and treatment of patients with low-risk Myelofibrosis or High-Risk Essential Thrombocythemia or ET Receving ET- Directed Therapy

Sponsor
Incyte

Protocol Number
INCB-MA-MF-401(MOST)

To Learn More Call
201-510-0910